Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...
Northcape Capital’s Wendy Herringer isn’t deterred by the 40 per cent crash in Novo Nordisk and is all in on this waste ...
Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
Long-term investments in top tech, health, and consumer staples for stability, growth, and reliable returns. Read what ...